Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation
Background. Liver transplantation (LT) is a curative treatment for hepatocellular carcinoma (HCC) and the underlying primary liver disease; however, tumor recurrence is still a major issue. Therefore, the aim of this study was to assess predictors and risk factors for HCC recurrence after LT in pati...
Main Authors: | Christin Bürger, Miriam Maschmeier, Anna Hüsing-Kabar, Christian Wilms, Michael Köhler, Martina Schmidt, Hartmut H. Schmidt, Iyad Kabar |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2019/5796074 |
Similar Items
-
Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?
by: David Kara, et al.
Published: (2018-01-01) -
Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine
by: Anna Hüsing, et al.
Published: (2015-08-01) -
Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01) -
Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
by: Sameer A Dhayat, et al.
Published: (2015-01-01) -
Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
by: Phil-Robin Tepasse, et al.
Published: (2021-06-01)